Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

B. I. Rini, G. Wilding, G. Hudes, W. M. Stadler, S. Kim, J. Tarazi, B. Rosbrook, P. C. Trask, L. Wood and J. P. Dutcher, “Phase II Study of Axitinib in Sorafenib- Refractory Metastatic Renal Cell Carcinoma,” Journal of Clinical Oncology, Vol. 27, No. 27, 2009, pp. 4462-4468. doi:10.1200/JCO.2008.21.7034

has been cited by the following article: